Wells Pharma of Houston LLC

Frequent Recalls

7

Recalls

0

Units Recalled

0

Injuries

0

Deaths

1 category · 2026-05-06 to 2026-05-06

Date	Source	Product	Brand	Severity	Units
2026-05-06	FDA Drug	FDA Recall: fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mcg/ 250 mL) (10 mcg p	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per mL), 100 mL bag, We	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pha	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma of Houston, NDC 7370	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells phar	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive,	Wells Pharma of Houston LLC	Class II	N/A
2026-05-06	FDA Drug	FDA Recall: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 mcg per mL), well ph	Wells Pharma of Houston LLC	Class II	N/A

Wells Pharma of Houston LLC Recalls | WatchRecall